In vivo transfection of hepatitis C virus complementary DNA into rodent liver by asialoglycoprotein receptor mediated gene delivery
Masato Yamamoto, Norio Hayashi, Yasuhide Miyamoto, Tetsuo Takehara, Eiji Mita, Makoto Seki, Hideyuki Fusamoto, Takenobu Kamada – 1 September 1995 – An in vivo model of hepatitis C virus (HCV) infection is needed to enable investigation of the mechanism of the liver injury that it causes. In this study, we used asialoglycoprotein receptor mediated gene delivery to obtain expression of the complementary DNA (cDNA) coding the core and part of the envelope 1 protein of HCV because selective delivery to the hepatocytes has been reported to be attained with this method.